More on
NPHCNPHC has a really nice chart, a huge run a few months ago and now it`s formed a really strong base.
Check it for yourself: http://bigcharts.marketwatch.com/quickchart/quickchart.aspsymbnphc&sid0&o_symbnphc&freq1&time7 It`s very possible the next leg up is around the corner. Make sure you keep an eye on this one!! Remember
NPHC has various pain reliever drugs ready for the market! Drug companies make a lot of money, some charge a few dollars a pill, and when you sell a common one that everyone needs it could be extraordinary for the company.
When you live everyday with pain you rely a lot on pain relievers just to function. This is what people with arthritis and multiple sclerosis (MS) have to deal with.
NPHC through its wholly-owned drug discovery subsidiary, ReceptoPharm, is developing proprietary therapeutic protein products primarily for the prevention and treatment of viral and neurological diseases in humans, including Multiple Sclerosis (MS).
It has been said that about 400k Americans have multiple sclerosis and every week, an estimated 200 more are diagnosed! The emphasis of ReceptoPharm`s approach to drug discovery and the development of new therapeutic agents is based upon specialized receptor-binding proteins found in nature, especially those found in snake venom from the cobra..
You can read about it here: http://www.nutrapharma.com/drug_discovery/
NPHC has granted XenaCare Holdings the exclusive license to market and distribute Cobroxin in the United States.
Cobroxin is the first OTC pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain!! Benefits to Cobroxin include:
* All Natural * Non-Addictive * Non-Narcotic * Non-Opiate * More Potent than Morphine * Long Lasting It has been said that more than 46 million Americans have some form of arthritis! The potential is huge for a pain reliever that is all natural and non addictive and has more potent than morphine!
NPHC should have a very big market considering that XenaCare Holdings announced last month that the Chain Drug Marketing Association (CDMA) will begin inventorying Cobroxin for redistribution to its member pharmacies.
The CDMA currently has over 6,000 independent pharmacy members throughout the United States! Frank Rizzo, President of XenaCare Holdings stated, "Having a presence in CDMA member pharmacies will help us build significant awareness about Cobroxin as we continue to expand the brand nationwide through retailers and our multimillion dollar national advertising campaign." XenaCare Holdings, Inc. has also become a national sponsor of the Arthritis Foundation at the National Proud Sponsor level! With the sponsorship of the Arthritis Foundation, Cobroxin may bear the Arthritis Foundation Proud Sponsor Logo on its packaging. This logo illustrates to consumers that Cobroxin is proud to support the Arthritis Foundation`s efforts to help people take control of arthritis.
Additionally, the Arthritis Foundation will work with XenaCare and other Proud Sponsors to help build awareness about Cobroxin through its magazine, Arthritis Today, its membership e-newsletter and on its website, Arthritis.org.
Recently
NPHC announced the introduction of Nyloxin OTC, another product for the treatment of chronic pain.
Nyloxin OTC, was also developed by
NPHC`s wholly-owned drug discovery subsidiary, ReceptoPharm.
Nyloxin OTC will be available as an oral spray for treating lower back pain, migraines, neck aches, shoulder pain, cramps and neuralgia and as a topical gel for treating joint pain and pain associated with repetitive stress and arthritis.
Nyloxin OTC will be marketed and sold internationally alongside the Company`s prescription pain reliever, Nyloxin Rx.
NPHC recently announced its intention to begin the drug registration process for its pain relievers in Canada, Europe, and South America. The Company expects to have these registrations completed in the near term and plans to subsequently launch Nyloxin Rx and Nyloxin OTC in those territories through select international licensees.
More information can be found at these websites:
http://www.NutraPharma.com http://www.XenaCareHoldings.com http://www.Cobroxin.com Always do your own research and consult with your own financial professional.*********************************************************
See Cool Penny Stocks's website for full disclaimer. Cool Penny Stocks may have received compensation for stock picks.
Home
